Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PDI Identifies 40 Potential Products For Sales Through LifeCycle X-Tension

Aug 20 2001

• By The Pink Sheet

Related Content

Novartis Lotensin

May 28 2001

Pfizer/PDI

Jul 23 2001

Ranbaxy Generic Ceftin May Clear FDA After USP Monograph Revision

Aug 20 2001

Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?

Aug 13 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window